SciELO - Scientific Electronic Library Online

 
vol.26 número3Epidemiología de los tumores hipofisarios tratados con radiocirugía con bisturí gamma en México: un estudio de un solo centroArteria cerebral media con variante tipo "rete" - fisiopatología y enfrentamiento imagenológico índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Revista mexicana de neurociencia

versión On-line ISSN 2604-6180versión impresa ISSN 1665-5044

Rev. mex. neurocienc. vol.26 no.3 Ciudad de México may./jun. 2025  Epub 15-Ago-2025

https://doi.org/10.24875/rmn.24000054 

Original articles

Etiological characterization of ischemic stroke in a neurovascular care unit in Mexico

Caracterización etiológica del ictus isquémico en una unidad de cuidados neurovasculares en México

Diego A. Ortega-Moreno1 

Emanuel Navarrete-Juárez1 

Ricardo López-Soto2 

Isaí Hernández-Padilla2 

Fernando Tienda-López1 

Alejandro González-Aquines2 

Adrián Infante-Valenzuela2 

Erick García-Valadez2 

Fernando Góngora-Rivera3  * 

1Servicio de Neurología, Facultad de Medicina

2Servicio de Neurología, Hospital Universitario Dr. José Eleuterio González

3Servicio de Neurología y Centro de Investigación y Desarrollo en Ciencias de la Salud, Hospital Universitario Dr. José Eleuterio González. Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico


Abstract

Objective:

This study aimed to elucidate the diagnostic experience of our neurovascular care unit (NCU) in managing consecutive cases of cerebral infarction, detailing the prevalence of etiologies using the Trial of Org 10172 in acute stroke registry (TOAST) classification and comparing it with prior Mexican studies.

Methods:

A descriptive study of consecutive cases was conducted on patients diagnosed with ischemic stroke hospitalized in our NCU from September 2019 to July 2022. Patients underwent standardized diagnostic assessments by internists and neurologists, including neuroimaging (computed tomography [CT] and/or magnetic resonance imaging of the brain) and complementary studies (carotid Doppler ultrasound, 24-h Holter monitoring, echocardiogram). All patients had TOAST etiological classification, National Institute of Health Stroke Scale, and modified Rankin Scale evaluations.

Results:

A total of 738 subjects (57% male and mean age of 61 years) were included. Hypertension (61%), diabetes (49%), and dyslipidemia (11%) were common risk factors. Neuroimaging was performed on 95.7% of patients, with CT being the most prevalent (72.8%). The TOAST classification revealed 31.3% atherothrombotic, 24.7% lacunar, 15.4% cardioembolic, and 25.5% cryptogenic cases.

Conclusions:

The establishment of NCUs enhances ischemic stroke management, improving patient outcomes and reducing recurrence. Until stroke units become widespread, a structured evaluation by trained specialist physicians remains essential.

Keywords Stroke; Etiology; Neurovascular care unit

Resumen

Objetivo:

Este estudio tuvo como objetivo detallar la experiencia diagnóstica de nuestra Unidad de Cuidados Neurovasculares (UCN) en el manejo de casos consecutivos de ictus isquémico, detallando la prevalencia de etiologías utilizando la clasificación TOAST y comparándola con estudios previos en México.

Métodos:

Se realizó un estudio descriptivo de casos consecutivos en pacientes diagnosticados con ictus isquémico-hospitalizados en nuestra Unidad de Cuidados Neurovasculares desde septiembre de 2019 hasta julio de 2022. Los pacientes fueron sometidos a evaluaciones diagnósticas estandarizadas por internistas y neurólogos, que incluyeron neuroimagen (TC y/o RMN cerebral) y estudios complementarios (ultrasonido Doppler carotídeo, monitoreo Holter de 24 horas, ecocardiograma). Todos los pacientes tuvieron clasificación etiológica TOAST, evaluaciones NIHSS y escala modificada de Rankin.

Resultados:

Se incluyeron un total de 738 sujetos (57% hombres, edad media 61 años). La hipertensión arterial (61%), la diabetes (49%) y la dislipidemia (11%) fueron factores de riesgo comunes. Se realizó neuroimagen en el 95.7% de los pacientes, siendo la TC la más prevalente (72.8%). La clasificación TOAST reveló casos aterotrombóticos (31.3%), lacunares (24.7%), cardioembólicos (15.4%) y criptogénicos (25.5%).

Conclusiones:

Un enfoque sistemático en la evaluación del ictus isquémico puede mejorar los resultados del paciente y reducir los riesgos de recurrencia, subrayando el papel fundamental de los médicos especialistas en el manejo del ictus isquémico dentro del sector de la salud pública.

Palabras clave Ictus isquémico; Etiología; Unidad de Cuidados Neurovasculares

Introduction

Ischemic stroke is one of the leading causes of death and disability worldwide1, as well as a major cause of hospitalization in neurology services. In 2019, the incidence of ischemic stroke in Mexico was 58.6/100,000 inhabitants, occurring in men in 56.5% of cases2. Ischemic stroke represents a significant public health issue globally, resulting in substantial clinical impairment in patients, associated residual disability, decreased work capacity, and socioeconomic burden on families3.

The etiological classification of ischemic stroke is a contentious issue in Mexico due to limited availability for patient evaluation, including laboratory and imaging studies. It is common for adjunct studies such as Doppler ultrasound of neck vessels, echocardiography, and imaging of intracranial arteries with magnetic resonance angiography or computed tomography (CT) angiography to be deferred to subsequent visits, leading to a higher percentage of cases with undetermined etiology.

Current guidelines for the management of acute cerebral infarction consider complementary studies essential for achieving accurate etiological definition and, consequently, better patient care. This becomes feasible with the presence of neurovascular care units (NCUs) or stroke units4 and the standardization of quality indicators, including complementary studies and therapeutic response times, thus improving patients’ functional status at discharge, preventing intrahospital complications, and stroke recurrence5-7.

The primary objective of this study was to detail the experience of our NCU in the standardized diagnostic approach of consecutive cerebral infarction patients, describing the prevalence of etiologies according to the Trial of Org 10172 in Acute Stroke Registry (TOAST) classification8 and comparing it with previous publications in Mexico.

Materials and methods

A descriptive study of consecutive cases was conducted, including patients diagnosed with ischemic stroke registered in the i-Registro-Neurovascular database of the Neurology Service at the "Dr. José Eleuterio González" University Hospital and hospitalized in our NCU between September 2019 and July 2022.

All included patients underwent standardized diagnostic evaluation by internists and neurologists, which consisted of an initial neuroimaging study (CT and/or magnetic resonance imaging [MRI] of the brain), as well as complementary studies for the etiological determination of cerebral infarction, including carotid Doppler ultrasound, 24-h Holter monitoring, and transthoracic echocardiogram (TTE) or transesophageal echocardiogram (TEE). All included patients underwent ischemic stroke classification according to the TOAST criteria8,9. Stroke etiology was determined as positive when classified as either probable-indicating strong clinical, imaging, and ancillary test support for a specific cause with most alternative etiologies excluded-or possible, where the available evidence suggested a particular cause, though further investigations might be required for definitive confirmation. If neither classification could be assigned with confidence, the stroke was designated as cryptogenic. This approach adhered to the original TOAST criteria established by Adams et al. In addition, the National Institute of Health Stroke Scale (NIHSS) and the modified Rankin Scale (mRS) were used for patient evaluation during their hospital stay.

Comorbidity was defined for patients who: (1) were known to have the disease, (2) had a personal history of the disease, or (3) were under treatment with medications. A sedentary lifestyle was defined as not engaging in physical activity beyond daily activities. Young stroke was defined for patients who had ischemic stroke before the age of 5510.

Categorical variables were reported as frequencies and percentages, whereas numerical variables were reported as measures of central tendency and dispersion. IBM SPSS Statistics version 25 was used for statistical analysis.

Results

A total of 738 subjects were included (57% male), with a mean age of 61 years (SD 14). The most prevalent risk factors within our sample were arterial hypertension (61%), diabetes mellitus (49%), and dyslipidemia (11%). 31% (n = 229) of cerebral infarctions occurred in patients under 55 years old. The average length of hospital stay was 8.66 days (SD 6.34). Upon admission, the mean NIHSS score was 8.07 points (SD 5.94). Regarding complications, 2.8% (n = 21) of patients suffered from cerebral hemorrhage/hemorrhagic transformation, and 1.5% (n = 11) suffered from a recurrent cerebral infarction. A complete description of patient characteristics is found in table 1.

Table 1 Population characteristics 

Baseline characteristics Total population (n = 738)
Sex (males), n (%) 419 (56.8)
Age (mean, SD) 61.17 (14)
Personal history, n (%)
Diabetes mellitus 363 (49.2)
Hypertension 450 (61)
Dyslipidemia 84 (11.4)
TIA 29 (3.9)
Smoking 311 (42.1)
Alcoholism 338 (45.8)
Substance abuse 42 (5.7)
Sedentary lifestyle 510 (69.1)
Admission assessment
NIHSS (mean, SD) 8.07 (5.94)
mRankin, n (%)
0-2 273 (37.0)
3-5 444 (60.2)
TOAST, n (%)
Atherothrombotic 231 (31.3)
Lacunar 182 (24.7)
Cardioembolic 114 (15.4)
Other determined cause 23 (3.1)
Cryptogenic 188 (25.5)
Complications, n (%)
Cardiovascular 4 (0.5)
Cerebral hemorrhage/Hemorrhagic transformation 21 (2.8)
Recurrent cerebral infarction 11 (1.5)
Urinary tract infections 7 (0.9)
Kidney failure 4 (0.5)
Pneumonia 14 (1.9)
Discharge evaluation
NIHSS (mean, SD) 5.68 (5.77)
mRankin, n (%)
0-2 384 (52.0)
3-5 312 (42.3)
Length of hospital stay (mean, SD) 8.66 (6.34)
In-hospital mortality, n (%) 20 (2.7)

TIA: transient ischemic attack; NIHSS: National Institutes of Health Stroke Scale; TOAST: trial of org 10172 in acute stroke treatment; SD: standard deviation.

The neuroimaging evaluation was performed on 95.7% of patients during hospital admission for suspected ischemic stroke, with non-contrast CT being the most frequently used, performed in 72.8% of cases. Subsequently, during hospitalization, complementary studies performed were: (1) angiotomography, magnetic resonance angiography, or transcranial Doppler in 95.3% of patients, for evaluation of intracranial vasculature; (2) Holter monitoring for at least 24 h in 64% of patients (although 92% had telemetry in their first 24 h of hospitalization); (3) TTE or TEE in 97.6% of patients; (4) Doppler ultrasound of the extracranial carotid and vertebral arteries in 92.7% of patients. A complete description of the imaging evaluation of patients is found in table 2.

Table 2 Diagnostic imaging 

Diagnostic imaging studies, n (%) Total population (n = 738)
Simple computed tomography 537 (72.8)
Simple magnetic resonance imaging 567 (76.8)
Computed tomography or magnetic resonance imaging 706 (95.7)
Computed tomography and magnetic resonance imaging 398 (53.9)
Angiotomography, magnetic resonance angiography, or transcranial Doppler 703 (95.3)
Carotid and vertebral Doppler ultrasound 684 (92.7)
24-h Holter monitor 471 (63.8)
Transthoracic echocardiogram (TTE) 535 (72.4)
Transesophageal echocardiogram (TEE) 25 (3.4)
Echocardiogram (ETT o ETE) 721 (97.6)

Regarding etiological classification by TOAST within our sample, following interpretation of clinical and paraclinical studies, 31.3% (n = 231) corresponded to atherothrombotic origin, 24.7% (n = 182) lacunar, 15.4% (n = 114) cardioembolic, and 3.1% (n = 23) of other determined etiology. Despite the clinical and paraclinical methodology used for patient evaluation, 25.5% (n = 188) were finally classified as having undetermined or cryptogenic etiology.

Among evaluated patients who experienced a cerebral infarction before the age of 55, 62.4% (n = 143) were male, and 14.4% (n = 33) had a history of previous cerebral infarction. Regarding the etiological origin of ischemic stroke, it was found that 24.5% (n = 56) were of atherothrombotic origin, 32.3% (n = 74) lacunar, 10.5% (n = 24) cardioembolic, 3.9% (n = 9) of other determined etiology, and 28.8% (n = 66) cryptogenic. At hospital discharge, 50% (n = 94) of this subgroup of patients had a score of 0-2 on the mRS. Complications included 3.1% (n = 7) suffering from cerebral hemorrhage/hemorrhagic transformation.

Discussion

Ischemic stroke remains one of the leading causes of morbidity and mortality globally. Its multifactorial nature demands both precise diagnosis and personalized treatment. In this context, specialist physicians and neurologists play a crucial role in the initial evaluation, identification of underlying causes, and final diagnosis of ischemic stroke, as well as in identifying factors contributing to the recurrence of this disease. Standardized evaluation is essential for minimizing resulting brain damage and optimizing patient prognosis11.

The etiological epidemiology of ischemic stroke in Mexico, as in other countries with economic health limitations, remains a poorly studied topic, with variable results according to available documented information2,12. Within the RENAMEVASC study, the cardioembolic subtype (24.7%) was designated as the most frequent etiological cause of ischemic stroke in Mexico, followed by lacunar (19.4%) and atherothrombotic (14.7%) subtypes. However, the classification of "Undetermined" as the ultimate cause of ischemic stroke corresponded to 36.6%, being the most frequent13. Similarly, in the subset of the PREMIER database, the most frequent etiological causes of ischemic stroke were cardioembolic (22%), lacunar (19%), and atherothrombotic (8%) subtypes. However, the “Cryptogenic” classification was also assigned a percentage of 42%14.

It is interesting to evaluate, within this subset, the analyzed data and the proportionality of the etiological causes of ischemic stroke in patients evaluated within public medical centers compared to private centers. In public medical centers, a proportion of cryptogenic ischemic stroke cases of 45% was reported, whereas in private centers, it was 28%, generating a reduction of 17%. In public centers, the main imaging study performed for the evaluation of patients with ischemic stroke corresponded to CT of the skull, whereas in private centers, it was MRI of the skull, together with transcranial and carotid Doppler ultrasound, angiography, and echocardiogram14.

On the other hand, Arauz et al. documented in the registry of the National Institute of Neurology and Neurosurgery that atherothrombotic was the most frequent etiological cause (25.1%), followed by cardioembolic and other determined etiology, with 24.5% and 17%, respectively. Truly cryptogenic etiology was documented in 6.4% of cases, and indeterminate cause with incomplete evaluation was documented in 11.2%. It is important to note that within their evaluation, 94.3% of patients underwent CT scans during their initial assessment, of which 71.77% underwent MRI after their initial assessment. Vascular evaluation was performed using cervical US in 50.4%, angio CT in 11.4%, and angio MRI in 18.3%. 34.5% underwent TTE as part of their evaluation. In addition, 12.9% of cases were evaluated using serum prothrombotic proteins15. A detailed comparison of etiological causes of acute ischemic stroke across different Mexican cohorts is presented in table 3.

Table 3 Etiological characterization 

Stroke etiology by TOAST classification iReNe 2022 (%) PREMIER 2018§ (%) PREMIER 2018 RENAMEVASC 2011 (%) Arauz, et al. 2018 (%)
Atherothrombotic 31.3 8 17 14.7 25.1
Lacunar 24.7 19 16 19.4 15.1
Cardioembolic 15.4 22 20 24.7 24.5
Other determined etiology 3.1 5 9 4.6 17
Cryptogenic 25.5 42 28 36.6 6.4
Mixed NR 5 9 NR NR

Etiological classification by TOAST in various studies.

§Data obtained from the general population. Data was obtained from private hospitals.

NR: not reported.

A thorough evaluation of cardiovascular risk factors is imperative to understand the etiology of ischemic stroke. Specialist physicians should conduct meticulous analyses of patients to detect comorbidities that could contribute to the development of this pathology16. Internists play a fundamental role in managing these conditions, which may require anticoagulant therapy, antiplatelet medications, or surgical interventions17. Furthermore, close collaboration among specialist physicians, such as internists, neurologists, cardiologists, and vascular surgeons, is essential to accurately determine the etiological cause of stroke, facilitating the provision of comprehensive care for ischemic stroke through a more complete evaluation and additional therapeutic plans18.

In situations where conventional risk factors do not fully explain the etiology of ischemic stroke, especially in patients < 55 years old, it is necessary to conduct a comprehensive investigation focused on possible underlying vasculopathy or coagulopathies, using specialized tests such as vascular imaging and thrombophilia panels, to identify less common but equally relevant causes of ischemic stroke18. By closely evaluating these risk factors and defining the etiology of ischemic stroke in patients, internists can take preventive measures to reduce the likelihood of occurrence or recurrence of a stroke19. In addition, routine health screening with prothrombotic screening coverage in patients under 55 years of age may help improve the determination of the cause of heart attack.

Recognizing and classifying the etiology of ischemic stroke, especially in populations with a high prevalence of cardiovascular risk factors, is essential for effective management of secondary prevention, improving short and long-term functional outcomes, reducing the burden of disability, improving quality of life, and reducing mortality related to this disease.

Conclusion

The establishment of NCUs enhances the initial evaluation, management, monitoring, and secondary prevention of patients with acute ischemic strokes. In the public health-care sector of our country, specialist physicians play a critical role in diagnosis, management, and risk factor identification, ensuring timely and accurate care, particularly in the absence of stroke units outside major urban centers. Until the widespread implementation of dedicated stroke units becomes feasible, adopting a standardized approach to ischemic stroke evaluation could substantially improve functional outcomes and reduce recurrence rates.

REFERENCES

1. Johnson CO, Nguyen M, Roth GA, Nichols E, Alam T, Abate D, et al. Global, regional, and national burden of stroke, 1990-2016:a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:439-58. [ Links ]

2. De la Cruz-Góngora VD, Chiquete E, Gómez-Dantés H, Cahuana-Hurtado L, Cantú-Brito C. Trends in the burden of stroke in Mexico:a national and subnational analysis of the global burden of disease 1990-2019. Lancet Reg Health Am. 2022;10:100204. [ Links ]

3. Feigin VL, Krishnamurthi R, Bhattacharjee R, Parmar P, Theadom A, Hussein T, et al. New strategy to reduce the global burden of stroke. Stroke. 2015;46:1740-7. [ Links ]

4. Jauch EC, Saver JL, Adams HP, Bruno A, Connors JJ, Demaerschalk BM, et al. Guidelines for the early management of patients with acute ischemic stroke:a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870-947. [ Links ]

5. Langhorne P, Ramachandra S, Stroke Unit Trialists'Collaboration. Organised inpatient (stroke unit) care for stroke:network meta-analysis. Cochrane Database Syst Rev. 2020;4:CD000197. [ Links ]

6. Seenan P, Long M, Langhorne P. Stroke units in their natural habitat:systematic review of observational studies. Stroke. 2007;38:1886-92. [ Links ]

7. Gilligan AK, Thrift AG, Sturm JW, Dewey HM, Macdonell RA, Donnan GA. Stroke units, tissue plasminogen activator, aspirin and neuroprotection:which stroke intervention could provide the greatest community benefit?Cerebrovasc Dis. 2005;20:239-44. [ Links ]

8. Chung JW, Park SH, Kim N, Kim WJ, Park JH, Ko Y, et al. Trial of ORG 10172 in acute stroke treatment (TOAST) classification and vascular territory of ischemic stroke lesions diagnosed by diffusion-weighted imaging. J Am Heart Assoc. 2014;3:e001119. [ Links ]

9. Adams HP Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24:35-41. [ Links ]

10. Béjot Y, Daubail B, Jacquin A, Durier J, Osseby GV, Rouaud O, et al. Trends in the incidence of ischaemic stroke in young adults between 1985 and 2011:the Dijon stroke registry. J Neurol Neurosurg Psychiatry. 2014;85:509-13. [ Links ]

11. Rizos T, Güntner J, Jenetzky E, Marquardt L, Reichardt C, Becker R, et al. Continuous stroke unit electrocardiographic monitoring versus 24-hour holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke. Stroke. 2012;43:2689-94. [ Links ]

12. Saposnik G, Del Brutto OH. Stroke in South America:a systematic review of incidence, prevalence, and stroke subtypes. Stroke. 2003;34:2103-7. [ Links ]

13. Cantú-Brito C, Ruiz-Sandoval J, Chiquete E, Arauz A, Leon-Jimenez C, Murillo-Bonilla LM, et al. Factores de riesgo, causas y pronóstico de los tipos de enfermedad vascular cerebral en México:estudio RENAMEVASC. Rev Mex Neurocienc. 2011;12:224-34. [ Links ]

14. Ruiz-Sandoval JL, Briseño-Godínez ME, Chiquete-Anaya E, Arauz-Góngora A, Troyo-Sanromán R, Parada-Garza JD, et al. Public and private hospital care disparities of ischemic stroke in Mexico:results from the primer registro Mexicano de isquemia cerebral (PREMIER) study. J Stroke Cerebrovasc Dis. 2018;27:445-53. [ Links ]

15. Arauz A, Marquez-Romero JM, Barboza MA, Serrano F, Artigas C, Murillo-Bonilla LM, et al. Mexican-national institute of neurology and neurosurgery-stroke registry:results of a 25-year hospital-based study. Front Neurol. 2018;9:207. [ Links ]

16. Ovbiagele B, Goldstein LB, Higashida RT, Howard VJ, Johnston SC, Khavjou OA, et al. Forecasting the future of stroke in the United States:a policy statement from the American Heart Association and American Stroke Association. Stroke. 2013;44:2361-75. [ Links ]

17. January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC Jr., et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation:a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2019;74:104-32. [ Links ]

18. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with acute ischemic stroke:2019 update to the 2018 guidelines for the early management of acute ischemic stroke:a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50:e344-418. [ Links ]

19. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42:1206-52. [ Links ]

FundingThe authors declare that this work was carried out with the authors’ own resources.

Ethical considerations

Protection of humans and animals. The authors declare that no experiments involving humans or animals were conducted for this research.

Confidentiality, informed consent, and ethical approval. The authors have followed their institution’s confidentiality protocols, obtained informed consent from patients, and received approval from the Ethics Committee. The SAGER guidelines were followed according to the nature of the study.

Declaration on the use of artificial intelligence. The authors declare that no generative artificial intelligence was used in the writing of this manuscript.

Received: October 02, 2024; Accepted: February 10, 2025

* Correspondence: Fernando Góngora-Rivera E-mail: fernando.gongora@hotmail.com

Conflicts of interest

The authors declare that they have no conflicts of interest.

Creative Commons License Instituto Nacional de Cardiología Ignacio Chávez. Published by Permanyer. This is an open ccess article under the CC BY-NC-ND license